ロード中...

Reducing the number of CTs performed to monitor personalized dosimetry during peptide receptor radionuclide therapy (PRRT)

BACKGROUND: Peptide receptor radionuclide therapy (PRRT) with [(177)Lu]-DOTA-TATE is an effective treatment of neuroendocrine tumors (NETs). After each cycle of treatment, patient dosimetry evaluates the radiation dose to the risk organs, kidneys, and bone marrow, the most radiosensitive tissues. Ab...

詳細記述

保存先:
書誌詳細
出版年:EJNMMI Phys
主要な著者: Chicheportiche, Alexandre, Artoul, Faozi, Schwartz, Arnon, Grozinsky-Glasberg, Simona, Meirovitz, Amichay, Gross, David J., Godefroy, Jeremy
フォーマット: Artigo
言語:Inglês
出版事項: Springer International Publishing 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6006002/
https://ncbi.nlm.nih.gov/pubmed/29916115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40658-018-0211-1
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!